As FRE rises 86% today on the news that it has marketing approval in US
Finally an effective nasal spray will be available in US - should Starpharma be putting in an application to FDA independent of there previous Vivagel Astodrimer sodium BV application which is stalled. Only yesterday I found that Nasodine was already listed on Australian Therapeutic Goods Register ATGR for overseas sales only so presumably that means it is manufactured in Australia. A couple of months ago they discontinued their AAT case re TGA decisions or lack thereof.
Does TGA put up road barriers to safe effective antiviral nasal sprays and WHY
Could this happen to Viraleze with marketing approval
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |